GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers is a research paper published in Nucleic Acids Research (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Human Genome Research Institute
Grant: R01HG011633
National Institute of Aging
Grant: R03AG070417
National Cancer Institute
Grant: R01CA262623
Cancer Prevention Research Institute of Texas
Grant: RR150085
Cancer Prevention Research Institute of Texas
Grant: RP190570
National Institutes of Health
Grant: 5R03AG070417-03
Characterization of Alternative Polyadenylation in Alzheimer's Disease
National Institutes of Health
Grant: 7R01CA262623-03
Systematic Characterization of Small Nucleolar RNAs in Cancer
National Institutes of Health
Grant: 5R01HG011633-06
MolQTL: A comprehensive resource for molecular quantitative trait loci inhuman cancer.
Texas A&M Institute of Biosciences and Technology
National Institutes of Health
FWCI
1.59
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals